Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Fluo-4 AM: Optimizing Calcium Imaging for Advanced Cell S...
2026-01-29
Unlock the full potential of intracellular calcium concentration measurement with Fluo-4 AM, the gold-standard fluorescent calcium indicator from APExBIO. Discover actionable workflow enhancements, expert troubleshooting advice, and real-world use-cases that are transforming calcium signaling assays and bioelectronic research.
-
Z-WEHD-FMK: Unveiling New Horizons in Caspase-5 Inhibitio...
2026-01-28
Explore the advanced scientific mechanisms and applications of Z-WEHD-FMK, a potent irreversible caspase-5 inhibitor, in inflammation and infectious disease research. This article offers unique insights into caspase signaling modulation and pyroptosis inhibition, setting it apart from existing resources.
-
Adefovir (SKU C6629): Data-Driven Solutions for Reliable ...
2026-01-28
This evidence-based article guides biomedical researchers and lab technicians through practical, scenario-driven challenges in hepatitis B virus (HBV) research, highlighting how Adefovir (SKU C6629) from APExBIO offers reproducible, high-quality results. Drawing on recent pharmacokinetic literature and peer benchmarks, the guide details best practices for experimental design, compatibility, optimization, and product selection, ensuring that scientists achieve robust, actionable data in cell-based antiviral assays.
-
Cell Counting Kit-8 (CCK-8) Plus: Scenario-Driven Best Pr...
2026-01-27
This article provides a scenario-based, data-backed exploration of laboratory challenges in cell viability and proliferation assays, highlighting how Cell Counting Kit-8 (CCK-8) Plus (SKU K2268) addresses issues of sensitivity, reproducibility, and workflow efficiency. Readers will gain actionable insights into assay optimization, product selection, and data interpretation, with direct links to validated protocols and scientific references.
-
BODIPY 581/591 C11: Ratiometric Lipid Peroxidation Detect...
2026-01-27
BODIPY 581/591 C11 empowers researchers with precise, ratiometric detection of lipid peroxidation and oxidative stress across live-cell and membrane models. Its robust performance, specificity to oxygen radicals, and compatibility with diverse workflows make it a gold standard for antioxidant capacity evaluation and ferroptosis research.
-
Liproxstatin-1: Potent Ferroptosis Inhibitor for Lipid Pe...
2026-01-26
Liproxstatin-1 is a potent ferroptosis inhibitor (IC50 22 nM) enabling precise modulation of lipid peroxidation in GPX4-deficient and iron-dependent cell death models. This article details its mechanism, benchmarks, and best practices for integration in ferroptosis research.
-
DIDS: Advanced Mechanisms and Emerging Roles in Cancer an...
2026-01-26
Explore the multifaceted actions of DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid), a premier anion transport inhibitor, with a deep dive into its unique molecular mechanisms and translational applications in cancer research and neurodegenerative disease models. This article offers a distinct, evidence-driven perspective on how DIDS is redefining chloride channel modulation and therapeutic innovation.
-
Sulfaphenazole: Strategic CYP2C9 Inhibition for Transform...
2026-01-25
This thought-leadership article examines Sulfaphenazole as a highly selective competitive CYP2C9 inhibitor, illuminating its mechanistic impact on drug metabolism, vascular endothelial function, and ischemia–reperfusion injury. Blending recent in vivo evidence and translational strategy, we delineate how APExBIO's Sulfaphenazole (C4131) empowers researchers to unravel pharmacogenetic complexities, modulate oxidative stress, and set new benchmarks for adverse drug reaction modeling beyond conventional product descriptions.
-
MDL 28170: Selective Calpain and Cathepsin B Inhibition f...
2026-01-24
MDL 28170 is a selective, cell-permeable calpain and cathepsin B inhibitor widely used in apoptosis and neuroprotection research. Its specificity, blood-brain barrier permeability, and nanomolar potency make it a benchmark tool for dissecting calpain-mediated proteolysis in ischemia-reperfusion and neurodegenerative models.
-
Q-VD-OPh: Pan-Caspase Inhibition as a Precision Tool for ...
2026-01-23
Explore the multifaceted roles of Q-VD-OPh, a potent pan-caspase inhibitor, in apoptosis research and mitochondrial quality control. This article uniquely connects irreversible caspase inhibition to emerging insights on mitophagy and disease modeling, providing advanced perspectives for experimental design.
-
U 46619 (SKU B6890): Practical Solutions for Reliable Pla...
2026-01-23
This article delivers scenario-based guidance for biomedical researchers and lab technicians seeking reproducible cell viability, platelet aggregation, and renal ischemia-reperfusion assays using U 46619 (SKU B6890). Drawing on quantitative data, peer-reviewed literature, and direct product comparisons, it demonstrates how U 46619 provides reliable, validated results and practical workflow advantages for demanding laboratory settings.
-
Pseudo-Modified Uridine Triphosphate (Pseudo-UTP): From M...
2026-01-22
This thought-leadership article illuminates the transformative role of pseudo-modified uridine triphosphate (Pseudo-UTP) in advancing mRNA vaccine and gene therapy pipelines. Integrating molecular mechanisms, peer-reviewed validation, and actionable strategy, it guides translational researchers through the evolving landscape of RNA modification, focusing on how Pseudo-UTP accelerates clinical innovation by enhancing RNA stability, translation efficiency, and reducing immunogenicity. With reference to recent breakthroughs and APExBIO’s high-purity offering, this piece provides a comprehensive resource that goes beyond standard product overviews.
-
S Tag Peptide: Fusion Tag for Enhanced Protein Solubility...
2026-01-22
Discover how the S Tag Peptide transforms protein engineering workflows as a versatile solubility enhancer and detection tag. Learn stepwise protocols, advanced applications in single-molecule imaging, and troubleshooting strategies that empower reproducible, high-sensitivity results across molecular biology platforms.
-
(S)-Mephenytoin (SKU C3414): Reliable CYP2C19 Assays for ...
2026-01-21
This comprehensive article addresses real-world challenges in drug metabolism and pharmacokinetic studies using (S)-Mephenytoin (SKU C3414) as a gold-standard CYP2C19 substrate. Drawing from current literature and validated protocols, it guides biomedical researchers, lab technicians, and postgraduates through experimental design, optimization, and vendor selection—emphasizing the reproducibility and reliability of (S)-Mephenytoin sourced from APExBIO.
-
MG-132 Proteasome Inhibitor: Applied Protocols & Troubles...
2026-01-21
MG-132, a potent cell-permeable proteasome inhibitor peptide aldehyde, is central to apoptosis research, cell cycle arrest studies, and oxidative stress investigations. This article delivers stepwise protocols, advanced applications, and expert troubleshooting tips to maximize the utility of MG-132 in molecular and cancer biology workflows.
15796 records 17/1054 page Previous Next First page 上5页 1617181920 下5页 Last page